UPLOAD Filing
MANGOCEUTICALS, INC.
Date: June 20, 2025 · CIK: 0001938046 · Accession: 0000000000-25-006464
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288039
Letter
Re: Mangoceuticals, Inc. Registration Statement on Form S-3 Filed June 13, 2025 File No. 333-288039 Dear Jacob D. Cohen:
June 20, 2025
Jacob D. Cohen Chief Executive Officer Mangoceuticals, Inc. 15110 N. Dallas Parkway, Suite 600 Dallas, Texas 75248
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: David M. Loev, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 20, 2025 Jacob D. Cohen Chief Executive Officer Mangoceuticals, Inc. 15110 N. Dallas Parkway, Suite 600 Dallas, Texas 75248 Re: Mangoceuticals, Inc. Registration Statement on Form S-3 Filed June 13, 2025 File No. 333-288039 Dear Jacob D. Cohen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: David M. Loev, Esq. </TEXT> </DOCUMENT>